HUP0101987A2 - Antibiotikus hatású proteinek és peptidek indukciója LAIT/sCD14-proteinnel - Google Patents

Antibiotikus hatású proteinek és peptidek indukciója LAIT/sCD14-proteinnel

Info

Publication number
HUP0101987A2
HUP0101987A2 HU0101987A HUP0101987A HUP0101987A2 HU P0101987 A2 HUP0101987 A2 HU P0101987A2 HU 0101987 A HU0101987 A HU 0101987A HU P0101987 A HUP0101987 A HU P0101987A HU P0101987 A2 HUP0101987 A2 HU P0101987A2
Authority
HU
Hungary
Prior art keywords
leu
protein
pro
scd14
lait
Prior art date
Application number
HU0101987A
Other languages
English (en)
Inventor
Dominik Filipp
Michael H. Julius
Original Assignee
Gemma Biotechnology Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemma Biotechnology Ltd. filed Critical Gemma Biotechnology Ltd.
Publication of HUP0101987A2 publication Critical patent/HUP0101987A2/hu
Publication of HUP0101987A3 publication Critical patent/HUP0101987A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A találmány tárgya eljárás szepszis tüneteinek enyhítésére, amelybenarra szoruló emlős epithelsejtjeit közvetlenül szolubilis CD14-proteinnel vagy annak aktív variánsával érintkeztetik. Ezen felül, aleírásban CD14 előállítására alkalmas eljárást ismertetnekemlőszekrétum-proteint tartalmazó törzsoldatból. A találmány tárgyatovábbá ejárás B-sejtek direkt aktiválására a 3C10 elnevezésűmonoklonális ellenanyag által specifikus módon felismert, B-sejtekreaktiváló hatású, leu-leu-leu-leu-leu-leu-pro-ser, leu-leu-leu-leu-leu-leu-pro-leu vagy leu-leu-leu-leu-leu-leu-val-his aminosav-szekvenciájúszolubilis polipeptidek valamelyikének alkalmazásával. Az említettekenfelül, szarvasmarha-eredetű CD14-et kódoló genomi DNS-t ismertetnek. Ó
HU0101987A 1998-05-27 1999-05-27 The induction of antibiotic peptides by lait (scd14) protein HUP0101987A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8688498P 1998-05-27 1998-05-27
PCT/CA1999/000482 WO1999061468A2 (en) 1998-05-27 1999-05-27 The induction of antibiotic peptides by lait (scd14) protein

Publications (2)

Publication Number Publication Date
HUP0101987A2 true HUP0101987A2 (hu) 2001-09-28
HUP0101987A3 HUP0101987A3 (en) 2010-01-28

Family

ID=22201526

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101987A HUP0101987A3 (en) 1998-05-27 1999-05-27 The induction of antibiotic peptides by lait (scd14) protein

Country Status (14)

Country Link
US (1) US7592310B2 (hu)
EP (1) EP1080111B1 (hu)
JP (1) JP2002516339A (hu)
CN (1) CN1322214A (hu)
AU (1) AU771448B2 (hu)
BR (1) BR9910725A (hu)
CA (1) CA2328134A1 (hu)
CZ (1) CZ20004256A3 (hu)
HK (1) HK1041892A1 (hu)
HU (1) HUP0101987A3 (hu)
ID (1) ID26730A (hu)
IL (1) IL139339A0 (hu)
PL (1) PL345208A1 (hu)
WO (1) WO1999061468A2 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022945A2 (en) * 1998-10-20 2000-04-27 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gastrointestinal tract disorder
WO2001072993A1 (fr) * 2000-03-31 2001-10-04 Mochida Pharmaceutical Co., Ltd. Inhibiteur de liaison entre le recepteur de type toll et cd14
JP4768620B2 (ja) 2003-05-15 2011-09-07 ジェネンテック， インコーポレイテッド 敗血症の予防及び治療のための方法及び組成物
CN1968962B (zh) * 2004-05-11 2013-07-24 持田制药株式会社 新型可溶性cd14抗原
US20100331239A1 (en) * 2008-01-29 2010-12-30 The Medical Research, Infrastructure And Health Services Cd14 and peptides thereof for protection of cells against cell death
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.
SG175142A1 (en) 2009-04-27 2011-12-29 Immuron Ltd Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
ES2628032T3 (es) 2010-08-17 2017-08-01 Immuron Limited Preparación de inmunoglobulina enriquecida con anti-LPS para su uso en el tratamiento y/o la profilaxis de un trastorno patológico
AU2012256682B2 (en) * 2011-05-19 2017-02-02 Mochida Pharmaceutical Co., Ltd. Diagnosis of respiratory tract infectious disease using blood specimens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) * 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
DK0485430T3 (da) * 1989-08-01 1999-06-14 Scripps Research Inst Fremgangsmåder og sammensætninger til bedring af symptomer på sepsis
EP0634935A4 (en) * 1992-04-06 1996-01-31 North Shore Univ Hospital A NEW THERAPY OF SEPSIS BY MEANS OF A SOLUBLE FORM OF RECOMBINANT CD14 MYELOMONOCYTIC ANTIGEN.
CA2163976C (en) * 1993-05-28 2010-06-29 Didier J. Leturcq Methods and compositions for inhibiting cd14 mediated cell activation
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
CA2208699A1 (en) * 1994-12-30 1996-07-11 Rockefeller University (The) Anti-inflammatory cd14 polypeptides
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
AU5688596A (en) 1995-04-13 1996-10-30 Deutsche Om Arzneimittel Gmbh Anti-cd14 antibodies for use in the induction of il-10 secre tion
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
EP1080111A2 (en) 2001-03-07
CN1322214A (zh) 2001-11-14
AU4025899A (en) 1999-12-13
CZ20004256A3 (cs) 2001-09-12
ID26730A (id) 2001-02-01
PL345208A1 (en) 2001-12-03
US7592310B2 (en) 2009-09-22
HUP0101987A3 (en) 2010-01-28
JP2002516339A (ja) 2002-06-04
US20040259795A1 (en) 2004-12-23
BR9910725A (pt) 2001-01-30
EP1080111B1 (en) 2012-07-25
WO1999061468A2 (en) 1999-12-02
AU771448B2 (en) 2004-03-25
IL139339A0 (en) 2001-11-25
HK1041892A1 (zh) 2002-07-26
CA2328134A1 (en) 1999-12-02
WO1999061468A3 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
Michel et al. Proteome analysis of human plasma and amniotic fluid by Off‐Gel™ isoelectric focusing followed by nano‐LC‐MS/MS
HK1059290A1 (en) Isolating cells expressing secreted proteins
EP2172486A3 (en) Monoclonal antibody against a prion protein and its use for the detection of prions
ATE329028T1 (de) Nl3 tie rezeptortyrosinekinase ligandhomologe
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
BR9809778A (pt) Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.
BRPI0616712B8 (pt) método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
HUP0101987A2 (hu) Antibiotikus hatású proteinek és peptidek indukciója LAIT/sCD14-proteinnel
Kunneken et al. Recombinant human laminin-5 domains: effects of heterotrimerization, proteolytic processing, and N-glycosylation on α3β1 integrin binding
BR9911270A (pt) Métodos e meios para expressão de polipeptìdeos de mamìferos em plantas monocotiledÈneas
Usami et al. Complement component C3 functions as an embryotrophic factor in early postimplantation rat embryos
WO2005010023A3 (en) Method for prediction of an epitope
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
Saito et al. Characterization of the post‐translational modification of recombinant human BMP‐15 mature protein
KR20070001874A (ko) 시료의 전처리방법 및 이를 이용한 면역학적 측정방법
WO2003089451A3 (en) Antibodies specific for mucin polypeptide
WO2003027149A1 (fr) Anticorps et utilisation de ce dernier
Hook et al. Proteolysis of ProPTHrP (1–141) by “prohormone thiol protease” at multibasic residues generates PTHrP-related peptides: implications for PTHrP peptide production in lung cancer cells
ATE398141T1 (de) Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung
AU2002341090A1 (en) Use of a protein of the crmp family for treating diseases related to the immune system
WO2003008626A3 (en) Novel human nucleic acids encoding a pantothenate kinase and methods of use
Kerjan et al. Mammalian prolyl-tRNA synthetase corresponds to the≈ 150 kDa subunit of the high-Mr aminoacyl-tRNA synthetase complex

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished